Stay updated with breaking news from Chiome Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An expert panel has proposed a new framework for the diagnosis and treatment of multiple sclerosis to replace the current subtype classifications, based on disease progression.
EQS-News: Heidelberg Pharma AG / Key word(s): Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the...
Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate
Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate13-Jul-2022 / 09:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014,...
FinancialContent fully hosted finance channel